by Ket Patel | Oct 5, 2012 | All Articles For Neurology, Headache/Migraine
Twenty-five percent of chronic migraine patients experience at least a 75% reduction in headache days per month after 6 months of treatment with onabotulinumtoxinA, according to a new analysis of data from the landmark PREEMPT trials. “That’s what I tell my...
by Ket Patel | Oct 5, 2012 | All Articles For Neurology, Headache/Migraine
Roughly 40% of the cost of 6 months of onabotulinumtoxinA for the treatment of chronic migraine is offset by resultant decreased use of emergency departments, urgent care facilities, and migraine-related hospitalizations, according to a prospective, real-world,...
by Ket Patel | Oct 4, 2012 | All Articles For Neurology, Stroke
Prof.Dr.C.Dettmers Kliniken Schmieder Konstanz, Konstanz, Germany; Faculty of Psychology, University Konstanz, Konstanz, Germany. Mental training has been widely recommended for stroke rehabilitation (Sharma, Pomeroy, & Baron, 2006). The potential value of motor...
by Ket Patel | Oct 4, 2012 | ADHD, All Articles For Psychiatry
An extended-release liquid formulation of methylphenidate, taken once a day, has been approved by the Food and Drug Administration for treating attention-deficit/hyperactivity disorder. The concentration of the oral suspension is 5 mg/mL. The recommended dose for...
by Ket Patel | Oct 2, 2012 | All Articles For Neurology, Multiple Sclerosis
Dr. Maria Pia Sormani Department of Health Sciences, University of Genova, Italy Victoria Murphy: My guest today is Dr. Maria Pia Sormani from the department of health sciences, university of Genova, Italy. Today we are here to discuss a paper you authored in The...